NCT07504458 2026-04-16
QUATRO-APL
Quetzal Therapeutics
Phase 3 Recruiting
Clinical Trials
5 trialsNCT06450145 2024-06-10
APL
Zhejiang Provincial People's Hospital
Phase NA Recruiting
NCT06088030 2024-01-03
Arsenic Trioxide Combined With Chemotherapy for the Treatment of p53-mutated Pediatric Cancer
Sun Yat-Sen Memorial Hospital of Sun Yat-Sen University
Phase 2 Recruiting
NCT04695223 2021-01-06
Arsenic Trioxide for Structural p53 Mutations
Shanghai Changzheng Hospital
Phase 2 Unknown
NCT00250042 2011-09-20
A Phase II Study of Gleevec and Arsenic Trioxide in Patients With CML Who Fail Gleevec
New Mexico Cancer Research Alliance
Phase 2 Completed